Amyloid-β load predicts medial temporal lobe dysfunction in Alzheimer dementia

J Nucl Med. 2013 Nov;54(11):1909-14. doi: 10.2967/jnumed.113.120378. Epub 2013 Oct 7.

Abstract

Amyloid-β (Aβ) deposition is a pathologic hallmark of Alzheimer disease (AD). Although the typical spatial distribution pattern of Aβ deposition in early AD mainly involves regions distant from the hippocampus, the predominant clinical feature is impairment of hippocampus-dependent memory. We aimed at elucidating the relationship between neocortical Aβ load, regional neuronal function, and memory impairment.

Methods: Thirty patients with early AD underwent combined (11)C-Pittsburgh compound B ((11)C-PIB) and (18)F-FDG PET and memory assessments. Composite measures of hemispheric Aβ load were calculated by volume-weighted mean values of neocortical (11)C-PIB binding. Voxelwise (18)F-FDG uptake was used as a measure of regional glucose metabolism reflecting neuronal activity. We investigated the relationship between left- and right-hemispheric Aβ load and regional glucose metabolism (voxelwise analyses). In addition, we assessed the correlations of hemispheric Aβ load (region-of-interest-based analyses) and regional glucose metabolism (voxelwise analysis) with memory performance. Analyses were corrected for age and sex.

Results: Higher Aβ load in the left hemisphere was associated with reduced glucose metabolism of the left medial temporal lobe (MTL; r(2) = 0.38) and correlated with worse wordlist recall (r = -0.37; partial correlation controlled for sex and age). Furthermore, wordlist recall correlated with regional glucose metabolism in the bilateral MTL and precuneus-posterior cingulate cortex and right lingual gyrus (r(2) = 0.24).

Conclusion: We demonstrated an association between the left-hemispheric Aβ load and impairment of the left MTL in AD at 2 different levels: regional hypometabolism and verbal memory. This correlation suggests that neocortical amyloid deposition is connected to or even drives neuronal dysfunction and neurodegeneration of the MTL, which is associated with impaired episodic memory processing as a clinical core symptom of AD.

Keywords: Alzheimer’s disease; Pittsburgh compound B; amyloid; episodic memory; positron emission tomography.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / diagnostic imaging
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / physiopathology
  • Amyloid beta-Peptides / metabolism*
  • Aniline Compounds
  • Benzothiazoles
  • Female
  • Fluorodeoxyglucose F18
  • Glucose / metabolism
  • Humans
  • Male
  • Memory
  • Positron-Emission Tomography
  • Temporal Lobe / diagnostic imaging
  • Temporal Lobe / metabolism
  • Temporal Lobe / physiopathology*
  • Thiazoles

Substances

  • 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
  • Amyloid beta-Peptides
  • Aniline Compounds
  • Benzothiazoles
  • Thiazoles
  • Fluorodeoxyglucose F18
  • Glucose